January 12, 2021
12. January – (Image: IO Biotech) The Lundbeck Foundation increases its commitment to IO Biotech as part of our 2030 strategy The Lundbeck Foundation is joining forces with IO Biotech’s other current owners, Novo Holdings and Sunstone, to invest in a major new Series B financing round in this immune-oncology specialist that is attracting significant...


The Lundbeck Foundation launches 2030 strategy with ambitious goals for grant and commercial activities
22. December 2020
Lundbeck foundation awards grants worth dkk 57 million to bold projects
15. December 2020
Cognitive training helped patients with bipolar disorder
9. December 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge